next ann:initiation of phase iia trial atl1103, page-12

SRF -

i do understand the whole Anti-sense scope the only reason i used the oil company comparison was to relate that one hit doen't mean they all hit. FWIW if Pfizer was convinced by the whole anti-sense portfolio & the potential for each & everyone of them they would of just moved on ISIS itself market cap is still very small in pharma terms for aquisiton, i mean ISIS is still well under a billion dollars. Pharma trying to manage blown out R&D budgets means many like to wait it out before throwing up the big figures only chasing proven products as opposed to exciting potential - hence why milestone deals tick the boxes hands on the potential but no commitment until proven.

Anyway that's all but I do expect the onslaught of TU's up to continue on the posts that chase "dreams".